论文部分内容阅读
一种消除血栓防止心脏病突发的天然制品已通过了首次试验。这种天然制品称作t-PA即“组织纤维蛋白溶酶原活化剂”,是从癌组织内提取的。该药试用于7位心脏病突发患者后表明,6位患者在一个小时内血柱消除。据美国密苏里州圣路易斯的华盛顿大学医学教授Philip Ludbrook博士声称,t-PA的前途在于能迅速恢复心肌的血流,使心肌的损害降低到最低限度,从而减少猝死病例。试验的结果还表明,用t-PA治疗不仅能防止心脏病突发,而且能改善心脏功能,为延长患者的寿命提供了综合性
A natural product that eliminates thrombosis and prevents heart attacks has passed its first trial. This natural product, called t-PA or “tissue plasminogen activator,” is extracted from cancerous tissue. The drug, tested on seven patients with a sudden heart attack, showed that six patients eliminated blood within an hour. According to Dr. Philip Ludbrook, a professor of medicine at Washington University in St. Louis, Missouri, USA, the future of t-PA is to rapidly restore myocardial blood flow and minimize myocardial damage, thereby reducing the number of sudden deaths. The results of the trial also showed that treatment with t-PA not only prevented heart attacks but also improved heart function, providing a comprehensive